The meaning of asymmetrical dimethylarginine Asymmetrical dimethylarginine (ADMA) is a naturally occurring compound in plasma. It is in the cytoplasm of human cells the protein modification process occurring metabolic by-products produced and ADMA has a close relationship with arginine. ADMA can affect the process of arginine nitric oxide. uefbbsdbks Asymmetrical dimethylarginine concentrations will be affected by normal or oxidized low-density lipoprotein cholesterol lot of improvement. Therefore, the high endothelial ADMA will increase the value of low-density lipoprotein, the emergence of a vicious circle, and hinders make vasodilator nitric oxide. But how to reduce asymmetrical dimethylarginine? Through the excretion of urea and need to dimethyl arginine dimethylamine hydrolase (DDAH) metabolism. In vivo generation Dimethylarginine dimethylamine hydrolase or polyphenol antioxidants can reduce homocysteine ??levels and reduce the risk of cardiovascular disease. Since asymmetric dimethyl arginine level be harmful, leading to such as cardiovascular diseases, metabolic diseases and other diseases of old age. So how to reduce ADMA levels which is an important outcome of the treatment. However, now it can not effectively control the ADMA levels and clinical experience, we just can use asymmetrical dimethylarginine elisa kit to detect the change in the concentration of asymmetrical dimethylarginine.http://www.cusabio.com/bio1-T-TPMT-7-7.html tpmt elisa kit
started by Johnny James on 06 Jan 14
Asymmetrical dimethylarginine (ADMA) is a naturally occurring compound in plasma. It is in the cytoplasm of human cells the protein modification process occurring metabolic by-products produced and ADMA has a close relationship with arginine. ADMA can affect the process of arginine nitric oxide. uefbbsdbks
Asymmetrical dimethylarginine concentrations will be affected by normal or oxidized low-density lipoprotein cholesterol lot of improvement. Therefore, the high endothelial ADMA will increase the value of low-density lipoprotein, the emergence of a vicious circle, and hinders make vasodilator nitric oxide. But how to reduce asymmetrical dimethylarginine? Through the excretion of urea and need to dimethyl arginine dimethylamine hydrolase (DDAH) metabolism. In vivo generation Dimethylarginine dimethylamine hydrolase or polyphenol antioxidants can reduce homocysteine ??levels and reduce the risk of cardiovascular disease.
Since asymmetric dimethyl arginine level be harmful, leading to such as cardiovascular diseases, metabolic diseases and other diseases of old age. So how to reduce ADMA levels which is an important outcome of the treatment. However, now it can not effectively control the ADMA levels and clinical experience, we just can use asymmetrical dimethylarginine elisa kit to detect the change in the concentration of asymmetrical dimethylarginine.http://www.cusabio.com/bio1-T-TPMT-7-7.html tpmt elisa kit